Leading industry expert with more than 25 years of experience in translation research in immunology BASEL, Switzerland, May 23, 2023 /PRNewswire/ — Engimmune Therapeutics AG (“Engimmune”), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, is pleased to…